Dataset from A Multi-Centre, Parallel, Double-Blind, Blinded Evaluator, Randomised, Placebo-Controlled Evaluation of the Efficacy and Safety of a Single Dose of 6 mL of Synvisc in Patients With Symptomatic Osteoarthritis of the Knee
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/PR00007615
下载链接
链接失效反馈官方服务：
资源简介：
This clinical study is to evaluate the safety and efficacy of hylan G-F 20 (Synvisc) in
patients with symptomatic knee osteoarthritis (OA). Patients will be given 6 mL of hylan G-F
20 (Synvisc) (or a phosphate buffered saline control), with a possible repeat treatment with
Synvisc after the week 26 visit.
创建时间：
2025-02-22
